Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Significance of Portal Hypertension After Cardiac Surgery

NCT03656263 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT03656263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03656263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Significance of Portal Hypertension After Cardiac Surgery
Lead sponsor
Montreal Heart Institute
Phase
Observational
Overall status
Completed
Start date
November 14, 2018
Completion date
February 20, 2021
Enrollment
360 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, congestive heart failure, right heart failure, surgery--complications, venous congestion